celgene
PreclinicalSmall molecule
celgene is one of 8 small molecule programs targeting Tendinopathy. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Tendinopathy
#DrugCompanyPhaseTrials
1Voltaren
NovartisApproved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Platelet Rich Plasma
ZZagazig University
Phase 3
Doryx
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 1
Aleve
Jazz PharmaceuticalsPreclinical
Naproxen Sodium
BayerPreclinical
Glyceryl - Trinitrate
PProcris Pharmaceuticals
Preclinical
celgene
AAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Tendinopathy1 trial
Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy
Withdrawn·—·N/A·NCT06712290
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for celgene. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details